Add like
Add dislike
Add to saved papers

E157Q integrase strand-transfer inhibitor substitution in patients with acute/recent HIV infection.

AIDS 2019 May 7
OBJECTIVES: Integrase strand-transfer inhibitor (InSTI)-based regimens are the preferred combinations for naïve HIV-infected individuals. Polymorphic substitutions that reduce InSTIs activity have been described, with E157Q being one of the most frequently found. This study aimed to evaluate the prevalence of E157Q substitution in newly diagnosed acute/recent HIV cases and the presence of transmission clusters.

DESIGN: Prospective cohort study in patients with acute/recent HIV infection METHODS:: Genotypic drug resistance tests were performed in all consecutive patients prospectively enrolled with a documented infection of less than six months from May 2015 to May 2017. Sequences were obtained by ultra-deep sequencing. Phylogenetic inferences were performed using maximum likelihood (ML) trees constructed with Mega 6.06. Bootstrap values of 75% or greater were defined for cluster assignment. Follow-up was, at least, one year.

RESULTS: In six out of 67 consecutive patients (8.95%, 95% CI 4.17-18.19) with acute/recent HIV infection, strains carrying the E157Q InSTI substitution were detected. All cases were men-who-have-sex-with-men patients infected with subtype B strains. No other resistance substitutions were detected in these cases. Median viral load was 5.33 (IQR: 4.54-5.71) log10 copies/mL and, in all cases, the mutational viral load was high (>95%). Three cases were included in transmission clusters. Three cases responded to dolutegravir-based regimens; non-nucleoside-reverse-transcriptase-inhibitor based regimens were used for the other case (s).

CONCLUSIONS: E157Q substitution, reducing raltegravir and elvitegravir activity, was frequently found in acute/recent HIV cases. All cases were infected with subtype B and some were included in clusters. Cases treated with dolutegravir-based regimens had good virological response.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app